13G Filing: EcoR1 Capital and Ovascience Inc. (NASDAQ:OVAS)

Page 5 of 7 – SEC Filing

Item 1.

(a) Name of Issuer

OvaScience, Inc.

(b) Address of Issuer’s Principal
Executive Offices

9 Fourth Avenue, Waltham, Massachusetts 02451

Item 2.

(a) The names of the persons filing this statement are:

EcoR1 Capital Fund Qualified, L.P. (“Qualified Fund”); EcoR1 Capital, LLC (“EcoR1”) and Oleg Nodelman
(“Nodelman”) (collectively, the “Filers”).

 

Qualified Fund is filing this statement jointly with the other Filers, but not as a member of a group and it expressly disclaims
membership in a group. In addition, filing this Schedule 13G on behalf of Qualified Fund should not be construed as an admission
that it is, and it disclaims that it is, a beneficial owner, as defined in Rule 13d-3 under the Act, of any of the Stock covered
by this Schedule 13G.

 

Each Filer also disclaims beneficial ownership of the Stock except to the extent of that person’s pecuniary interest
therein.

 

(b) The principal business office of the Filers is located at:

409 Illinois Street, San Francisco, CA 94158
(c) For citizenship of Filers, see Item 4 of the cover sheet for each Filer.
(d) This statement relates to shares of Common Stock, par value $0.001 per share of the Issuer (the “Stock”).
(e) The CUSIP number of the Issuer is: 69014Q101.
5

Follow Tempest Therapeutics Inc. (NASDAQ:TPST)